The University of Southampton
University of Southampton Institutional Repository

Maternal B-vitamin and vitamin D status before, during, and after pregnancy and the influence of supplementation preconception and during pregnancy: prespecified secondary analysis of the NiPPeR double-blind randomized controlled trial

Maternal B-vitamin and vitamin D status before, during, and after pregnancy and the influence of supplementation preconception and during pregnancy: prespecified secondary analysis of the NiPPeR double-blind randomized controlled trial
Maternal B-vitamin and vitamin D status before, during, and after pregnancy and the influence of supplementation preconception and during pregnancy: prespecified secondary analysis of the NiPPeR double-blind randomized controlled trial

Background Maternal vitamin status preconception and during pregnancy has important consequences for pregnancy outcome and offspring development. Changes in vitamin status from preconception through early and late pregnancy and postpartum have been inferred from cross-sectional data, but longitudinal data on vitamin status from preconception throughout pregnancy and postdelivery are sparse. As such, the influence of vitamin supplementation on vitamin status during pregnancy remains uncertain. This study presents one prespecified outcome from the randomized controlled NiPPeR trial, aiming to identify longitudinal patterns of maternal vitamin status from preconception, through early and late pregnancy, to 6 months postdelivery, and determine the influence of vitamin supplementation. Methods and findings In the NiPPeR trial, 1,729 women (from the United Kingdom, Singapore, and New Zealand) aged 18 to 38 years and planning conception were randomized to receive a standard vitamin supplement (control; n = 859) or an enhanced vitamin supplement (intervention; n = 870) starting in preconception and continued throughout pregnancy, with blinding of participants and research staff. Supplement components common to both treatment groups included folic acid, p-carotene, iron, calcium, and iodine; components additionally included in the intervention group were riboflavin, vitamins B6, B12, and D (in amounts available in over-the-counter supplements), myo-inositol, probiotics, and zinc. The primary outcome of the study was glucose tolerance at 28 weeks’ gestation, measured by oral glucose tolerance test. The secondary outcome reported in this study was the reduction in maternal micronutri-ent insufficiency in riboflavin, vitamin B6, vitamin B12, and vitamin D, before and during pregnancy. We measured maternal plasma concentrations of B-vitamins, vitamin D, and markers of insufficiency/deficiency (homocysteine, hydroxykynurenine-ratio, methylmalonic acid) at recruitment, 1 month after commencing intervention preconception, in early pregnancy (7 to 11 weeks’ gestation) and late pregnancy (around 28 weeks’ gestation), and postdelivery (6 months after supplement discontinuation). We derived standard deviation scores (SDS) to characterize longitudinal changes among participants in the control group and measured differences between the 2 groups. At recruitment, the proportion of patients with marginal or low plasma status was 29.2% for folate (<13.6 nmol/L), 7.5% and 82.0% for riboflavin (<5 nmol/L and <26.5 nmol/L, respectively), 9.1% for vitamin B12 (<221 pmol/L), and 48.7% for vitamin D (<50 nmol/L); these proportions were balanced between the groups. Over 90% of all participants had low or marginal status for one or more of these vitamins at recruitment. Among participants in the control group, plasma concentrations of riboflavin declined through early and late pregnancy, whereas concentrations of 25-hydroxyvitamin D were unchanged in early pregnancy, and concentrations of vitamin B6 and B12 declined throughout pregnancy, becoming >1 SDS lower than baseline by 28 weeks gestation. In the control group, 54.2% of participants developed low late-pregnancy vitamin B6 concentrations (pyridoxal 5-phosphate <20 nmol/L). After 1 month of supplementation, plasma concentrations of supplement components were substantially higher among participants in the intervention group than those in the control group: riboflavin by 0.77 SDS (95% CI 0.68 to 0.87, p < 0.0001), vitamin B6 by 1.07 SDS (0.99 to 1.14, p < 0.0001), vitamin B12 by 0.55 SDS (0.46 to 0.64, p < 0.0001), and vitamin D by 0.51 SDS (0.43 to 0.60, p < 0.0001), with higher levels in the intervention group maintained during pregnancy. Markers of vitamin insufficiency/deficiency were reduced in the intervention group, and the proportion of participants with vitamin D insufficiency (<50 nmol/L) during late pregnancy was lower in the intervention group (35.1% versus 8.5%; p < 0.0001). Plasma vitamin B12 remained higher in the intervention group than in the control group 6 months postdelivery (by 0.30 SDS (0.14, 0.46), p = 0.0003). The main limitation is that generalizability to the global population is limited by the high-resource settings and the lack of African and Amerindian women in particular.

1549-1277
e1004260
Godfrey, Keith M.
0931701e-fe2c-44b5-8f0d-ec5c7477a6fd
Titcombe, Philip
a84c9fad-0580-42f9-8bb6-db0fe20435aa
El-Heis, Sarah
5fe4aa5a-3655-4f22-bd82-3d992c18f16a
Albert, Benjamin B.
c2bf4926-6214-421d-b187-91c83966effc
Tham, Elizabeth Huiwen
e22014ec-8242-478a-aafc-e4177164f814
Barton, Sheila J.
4f674382-ca0b-44ad-9670-e71a0b134ef0
Kenealy, Timothy
c032e16b-65a8-4156-bc79-422f6c0e7079
Chong, Mary Foong-Fong
1e188259-b1ab-4448-9e65-5b6a0fd99502
Nield, Heidi
837b180c-0a9e-49ba-bc2e-a899ef761d34
Chong, Yap Seng
7043124b-e892-4d4b-8bb7-6d35ed94e136
Chan, Shiao-Yng
3c9d8970-2cc4-430a-86a7-96f6029a5293
Cutfield, Wayne S.
f9d25ea9-f2d7-433d-81fc-efd628cae5b0
NiPPeR Study Group
Godfrey, Keith M.
0931701e-fe2c-44b5-8f0d-ec5c7477a6fd
Titcombe, Philip
a84c9fad-0580-42f9-8bb6-db0fe20435aa
El-Heis, Sarah
5fe4aa5a-3655-4f22-bd82-3d992c18f16a
Albert, Benjamin B.
c2bf4926-6214-421d-b187-91c83966effc
Tham, Elizabeth Huiwen
e22014ec-8242-478a-aafc-e4177164f814
Barton, Sheila J.
4f674382-ca0b-44ad-9670-e71a0b134ef0
Kenealy, Timothy
c032e16b-65a8-4156-bc79-422f6c0e7079
Chong, Mary Foong-Fong
1e188259-b1ab-4448-9e65-5b6a0fd99502
Nield, Heidi
837b180c-0a9e-49ba-bc2e-a899ef761d34
Chong, Yap Seng
7043124b-e892-4d4b-8bb7-6d35ed94e136
Chan, Shiao-Yng
3c9d8970-2cc4-430a-86a7-96f6029a5293
Cutfield, Wayne S.
f9d25ea9-f2d7-433d-81fc-efd628cae5b0

Godfrey, Keith M., Titcombe, Philip, El-Heis, Sarah, Albert, Benjamin B., Tham, Elizabeth Huiwen, Barton, Sheila J., Kenealy, Timothy, Chong, Mary Foong-Fong, Nield, Heidi, Chong, Yap Seng, Chan, Shiao-Yng and Cutfield, Wayne S. , NiPPeR Study Group (2023) Maternal B-vitamin and vitamin D status before, during, and after pregnancy and the influence of supplementation preconception and during pregnancy: prespecified secondary analysis of the NiPPeR double-blind randomized controlled trial. PLoS Medicine, 20 (12 December), e1004260, [e1004260]. (doi:10.1371/journal.pmed.1004260).

Record type: Article

Abstract

Background Maternal vitamin status preconception and during pregnancy has important consequences for pregnancy outcome and offspring development. Changes in vitamin status from preconception through early and late pregnancy and postpartum have been inferred from cross-sectional data, but longitudinal data on vitamin status from preconception throughout pregnancy and postdelivery are sparse. As such, the influence of vitamin supplementation on vitamin status during pregnancy remains uncertain. This study presents one prespecified outcome from the randomized controlled NiPPeR trial, aiming to identify longitudinal patterns of maternal vitamin status from preconception, through early and late pregnancy, to 6 months postdelivery, and determine the influence of vitamin supplementation. Methods and findings In the NiPPeR trial, 1,729 women (from the United Kingdom, Singapore, and New Zealand) aged 18 to 38 years and planning conception were randomized to receive a standard vitamin supplement (control; n = 859) or an enhanced vitamin supplement (intervention; n = 870) starting in preconception and continued throughout pregnancy, with blinding of participants and research staff. Supplement components common to both treatment groups included folic acid, p-carotene, iron, calcium, and iodine; components additionally included in the intervention group were riboflavin, vitamins B6, B12, and D (in amounts available in over-the-counter supplements), myo-inositol, probiotics, and zinc. The primary outcome of the study was glucose tolerance at 28 weeks’ gestation, measured by oral glucose tolerance test. The secondary outcome reported in this study was the reduction in maternal micronutri-ent insufficiency in riboflavin, vitamin B6, vitamin B12, and vitamin D, before and during pregnancy. We measured maternal plasma concentrations of B-vitamins, vitamin D, and markers of insufficiency/deficiency (homocysteine, hydroxykynurenine-ratio, methylmalonic acid) at recruitment, 1 month after commencing intervention preconception, in early pregnancy (7 to 11 weeks’ gestation) and late pregnancy (around 28 weeks’ gestation), and postdelivery (6 months after supplement discontinuation). We derived standard deviation scores (SDS) to characterize longitudinal changes among participants in the control group and measured differences between the 2 groups. At recruitment, the proportion of patients with marginal or low plasma status was 29.2% for folate (<13.6 nmol/L), 7.5% and 82.0% for riboflavin (<5 nmol/L and <26.5 nmol/L, respectively), 9.1% for vitamin B12 (<221 pmol/L), and 48.7% for vitamin D (<50 nmol/L); these proportions were balanced between the groups. Over 90% of all participants had low or marginal status for one or more of these vitamins at recruitment. Among participants in the control group, plasma concentrations of riboflavin declined through early and late pregnancy, whereas concentrations of 25-hydroxyvitamin D were unchanged in early pregnancy, and concentrations of vitamin B6 and B12 declined throughout pregnancy, becoming >1 SDS lower than baseline by 28 weeks gestation. In the control group, 54.2% of participants developed low late-pregnancy vitamin B6 concentrations (pyridoxal 5-phosphate <20 nmol/L). After 1 month of supplementation, plasma concentrations of supplement components were substantially higher among participants in the intervention group than those in the control group: riboflavin by 0.77 SDS (95% CI 0.68 to 0.87, p < 0.0001), vitamin B6 by 1.07 SDS (0.99 to 1.14, p < 0.0001), vitamin B12 by 0.55 SDS (0.46 to 0.64, p < 0.0001), and vitamin D by 0.51 SDS (0.43 to 0.60, p < 0.0001), with higher levels in the intervention group maintained during pregnancy. Markers of vitamin insufficiency/deficiency were reduced in the intervention group, and the proportion of participants with vitamin D insufficiency (<50 nmol/L) during late pregnancy was lower in the intervention group (35.1% versus 8.5%; p < 0.0001). Plasma vitamin B12 remained higher in the intervention group than in the control group 6 months postdelivery (by 0.30 SDS (0.14, 0.46), p = 0.0003). The main limitation is that generalizability to the global population is limited by the high-resource settings and the lack of African and Amerindian women in particular.

Text
journal.pmed.1004260 - Version of Record
Available under License Creative Commons Attribution.
Download (1MB)

More information

Accepted/In Press date: 1 November 2023
e-pub ahead of print date: 5 December 2023
Published date: December 2023
Additional Information: Publisher Copyright: © 2023 Godfrey et al.

Identifiers

Local EPrints ID: 485486
URI: http://eprints.soton.ac.uk/id/eprint/485486
ISSN: 1549-1277
PURE UUID: e031f5a1-ea1a-47fa-8f8b-32993b8143b2
ORCID for Keith M. Godfrey: ORCID iD orcid.org/0000-0002-4643-0618
ORCID for Philip Titcombe: ORCID iD orcid.org/0000-0002-7797-8571
ORCID for Sheila J. Barton: ORCID iD orcid.org/0000-0003-4963-4242

Catalogue record

Date deposited: 07 Dec 2023 17:34
Last modified: 15 Aug 2024 01:45

Export record

Altmetrics

Contributors

Author: Philip Titcombe ORCID iD
Author: Sarah El-Heis
Author: Benjamin B. Albert
Author: Elizabeth Huiwen Tham
Author: Timothy Kenealy
Author: Mary Foong-Fong Chong
Author: Heidi Nield
Author: Yap Seng Chong
Author: Shiao-Yng Chan
Author: Wayne S. Cutfield
Corporate Author: NiPPeR Study Group

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×